Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the hypnotic efficacy of zolpidem-MR 12.5
mg in comparison with placebo, when administered over a long-term period, on an "as needed"
basis, in patients with chronic primary insomnia.
Secondary objectives of the study are to evaluate the drug taking behavior over a long-term
period and the clinical safety and tolerability of zolpidem-MR 12.5 mg in comparison to
placebo administered over a long-term period, on an as needed basis.